September 24, 2020 Comments Off on New patent for Optinose Us drug XHANCE Posted in: Patent Added Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. There are sixteen patents protecting this drug. XHANCE drug…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatent…
September 24, 2020 Comments Off on New patent for Janssen Pharms drug INVEGA SUSTENNA Posted in: Patent Added Annual Drug Patent Expirations for INVEGA+SUSTENNA Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent for Janssen Pharms drug INVEGA SUSTENNA appeared fi…